Topic: MedTech

A total of 10 patients will be enrolled into the feasibility study, which, if successful, will lead to a larger erectile dysfunction study involving around 50 patients.

MedAlliance announced today that it enrolled the first patient in an erectile dysfunction (ED) feasibility study […]

Strata Skin Sciences (NSDQ:SSKN) announced that it acquired the Pharos dermatology business from Ra Medical (NYSE:RMED). Horsham, Pa.-based […]

Zimmer Biomet (NYSE:ZBH) today announced that it received FDA 510(k) clearance for its Rosa Hip system […]

Abiomed (NSDQ:ABMD) today announced that the FDA has granted breakthrough device designation for its Impella ECP […]

Swing Therapeutics has emerged from stealth mode with the achievement of several key business and regulatory milestones.

Freudenberg Medical recently announced that it has increased its catheter sensor integration capabilities. The expanded capabilities […]

Insightec has announced that Seoul National University Hospital (SNUH) is installing the company’s Exablate Neuro […]

ResMed (NYSE:RMD) has debuted its next-generation positive airway pressure (PAP) device, AirSense 11. San Diego–based ResMed’s […]

Abbott today announced that it has received FDA approval for its Amplatzer Amulet device to […]

Able Medical Devices recently announced that its Mach screw clip system has received FDA 510(k) […]

Globus Medical recently announced that it has received FDA 510(k) clearance for its Excelsius3D intelligent […]

Aerin Medical today touted one-year results from a trial evaluating the safety and efficacy of its […]

Sinomed announced today that it completed the first commercial implantation of its HT Supreme drug-eluting […]

Ultromics’ EchoGo Core and EchoGo Pro platforms quickly deliver highly accurate assessments of heart function that support the diagnosis of coronary artery disease.

The Irvine, CA-based company said its ALIGN-AR pivotal trial will evaluate its Trilogy Heart Valve system.

Dive Brief: Abbott Laboratories received FDA approval for its Amplatzer Amulet left atrial appendage occluder device used […]

Memic is betting the small size of its device and potential to enable more hysterectomies to be done vaginally as differentiators that will enable it to grow sales to $136 million in 2025.

BrainQ, an Israeli stroke therapy technology company, closed a funding round worth $40 million. Hanaco […]

Memic Innovative Surgery is merging with MedTech Acquisition Corp. to go public.

The Xplore2/Pivotal study is for patients requiring right ventricular outflow tract (RVOT) reconstruction to correct certain congenital heart defects.

MedAlliance announced today that it closed patient enrollment for its clinical trial of the Selution SLR […]

Exactech this week announced that it has expanded its Truliant total knee system with a […]

Dive Brief: Almost two-third of manufacturers of novel technology devices plan to bring their products […]

Dive Brief: The National Evaluation System for health Technology (NESTcc) is seeking feedback on plans to add […]

Global health IT provider Royal Philips has launched a slew of products this week at HIMSS’ annual healthcare conference in Las Vegas.

The diagnostic software runs on Lunit’s AI technology to spot major abnormal findings.

Stryker (NYSE:SYK) announced today that it launched its next-generation SurgiCount + safety-sponge system.Kalamazoo, Mich.-based Stryker […]

Tiny and precise, smarter 6DOF wire-winding technologies can increase surgical access and improve outcomes. Minimally […]

As the effects of the COVID-19 pandemic continue, Daniel Sciubba (New York, USA), discusses how […]

Boston Scientific (NYSE:BSX) announced today that it received FDA 510(k) clearance for its Exalt Model B […]

The US Food and Drug Administration (FDA) has granted 510(k) approval for STAGE (STrategically Acquired […]

Here’s why medtech companies must embrace innovation, connectivity and disruption. DeviceTalks Healthcare must shift away […]

Nanox Imaging said it would acquire Zebra Medical Vision for $100 million with a potential for $100 million in milestone payments. The company will also acquire USARAD for $30 million.

Shockwave Medical (NSDQ:SWAV) shares ticked up today on second-quarter results that topped the consensus forecast. The […]

The medtech industry has been rising for weeks and the latest seven-day stretch was no […]

Intuitive Surgical (NASDAQ: ISRG) will spend more than $500 million to expand its Peachtree Corners […]

VenoValve has the potential to offer relief for patients that suffer from severe chronic venous insufficiency (CVI) in the deep veins of their legs.

The trial is the first study to compare interventional therapy in combination with anticoagulation vs. anticoagulation alone for pulmonary embolism.